StockData
Marpai, Inc. logo

Marpai, Inc. (MRAI) stock

MRAIOTCServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 0/30
$3.18+0.05 (+1.60%)

Close on Oct 19, 2026Market cap $82.24MP/E –Yield –

Marpai r&d expenses

Research and development expenses are spending on new products and technology.

Marpai's R&D Expenses for the twelve months ending Dec 31, 2025 was $7.00K, down 75.9% year over year. For fiscal 2025 it was $7.00K, down 75.9% from the year before. The highest annual figure on record is $3.71M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.00K-75.9%
FY2024Dec 31, 2024$29.00K-97.8%
FY2023Dec 31, 2023$1.31M-64.6%
FY2022Dec 31, 2022$3.71M+113.8%
FY2021Dec 31, 2021$1.73M-1.8%
FY2020Dec 31, 2020$1.77M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$0-100.0%
Q1 FY2025Mar 31, 2025$7.00K0.0%
Q4 FY2024Dec 31, 2024$7.00K-65.0%
Q3 FY2024Sep 30, 2024$7.00K-97.4%
Q2 FY2024Jun 30, 2024$8.00K-98.5%
Q1 FY2024Mar 31, 2024$7.00K-98.6%
Q4 FY2023Dec 31, 2023$20.00K-98.0%
Q3 FY2023Sep 30, 2023$267.00K-65.8%
Q2 FY2023Jun 30, 2023$523.00K-60.1%
Q1 FY2023Mar 31, 2023$500.00K-15.7%
Q4 FY2022Dec 31, 2022$1.02M+66.3%
Q3 FY2022Sep 30, 2022$781.75K+37.4%
Q2 FY2022Jun 30, 2022$1.31M+358.8%
Q1 FY2022Mar 31, 2022$593.11K+124.7%
Q4 FY2021Dec 31, 2021$615.77K+128.5%
Q3 FY2021Sep 30, 2021$568.82K+20.8%
Q2 FY2021Jun 30, 2021$285.36K–
Q1 FY2021Mar 31, 2021$264.01K–
Q4 FY2020Dec 31, 2020$269.46K–
Q3 FY2020Sep 30, 2020$470.94K–

More Marpai figures

See a number that looks wrong?